ATE442153T1 - Zusammensetzungen für die verbesserung der darmgesundheit und der tierischen leistung enthaltend beta-glucans and alfa-fucans - Google Patents

Zusammensetzungen für die verbesserung der darmgesundheit und der tierischen leistung enthaltend beta-glucans and alfa-fucans

Info

Publication number
ATE442153T1
ATE442153T1 AT06809743T AT06809743T ATE442153T1 AT E442153 T1 ATE442153 T1 AT E442153T1 AT 06809743 T AT06809743 T AT 06809743T AT 06809743 T AT06809743 T AT 06809743T AT E442153 T1 ATE442153 T1 AT E442153T1
Authority
AT
Austria
Prior art keywords
fucans
glucans
compositions
alfa
containing beta
Prior art date
Application number
AT06809743T
Other languages
English (en)
Inventor
John O'doherty
John O'sullivan
Aditya Julka
Original Assignee
Bioatlantis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioatlantis Ltd filed Critical Bioatlantis Ltd
Application granted granted Critical
Publication of ATE442153T1 publication Critical patent/ATE442153T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Fodder In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AT06809743T 2005-11-21 2006-11-21 Zusammensetzungen für die verbesserung der darmgesundheit und der tierischen leistung enthaltend beta-glucans and alfa-fucans ATE442153T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IES20050772 2005-11-21
PCT/IE2006/000131 WO2007057873A2 (en) 2005-11-21 2006-11-21 Novel compositions to improve gut health and animal performance and methods of making the same

Publications (1)

Publication Number Publication Date
ATE442153T1 true ATE442153T1 (de) 2009-09-15

Family

ID=38049053

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06809743T ATE442153T1 (de) 2005-11-21 2006-11-21 Zusammensetzungen für die verbesserung der darmgesundheit und der tierischen leistung enthaltend beta-glucans and alfa-fucans

Country Status (9)

Country Link
US (4) US20090148414A1 (de)
EP (1) EP1965809B9 (de)
AT (1) ATE442153T1 (de)
DE (1) DE602006009144D1 (de)
DK (1) DK1965809T3 (de)
ES (1) ES2333259T3 (de)
PL (1) PL1965809T3 (de)
PT (1) PT1965809E (de)
WO (1) WO2007057873A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210346443A1 (en) * 2005-11-21 2021-11-11 Bioatlantis Limited Novel Composition to Improve Gut Health and Animal Performance and Methods of Making the Same
WO2007057873A2 (en) 2005-11-21 2007-05-24 Bioatlantis Limited Novel compositions to improve gut health and animal performance and methods of making the same
SI2245945T1 (sl) * 2009-04-30 2013-06-28 Tiense Suikerraffinaderij N.V. Postopek hranjenja gojene svinje
DK2432478T3 (da) 2009-05-21 2021-12-06 Bioatlantis Ltd Forbedring af gastrointestinal sundhed, immunitet og ydeevne gennem kostintervention
US9463169B2 (en) 2011-08-17 2016-10-11 Microbiome Therapeutics, Llc Human gastrointestinal microbiome modulating food supplement for improving blood glucose regulation
EP4470377A3 (de) * 2013-03-20 2025-03-19 Bioatlantis Limited Nichtnematizide zusammensetzung und verwendung davon
ITPD20130133A1 (it) * 2013-05-14 2014-11-15 Sanypet S P A Prodotto per l'alimentazione di cani affetti da disturbi infiammatori dell'intestino
CN104031158B (zh) * 2014-06-10 2016-08-17 浙江宇翔生物科技有限公司 一种从海带中提取硫酸酯多糖的工艺
KR102205829B1 (ko) 2017-06-14 2021-01-21 기초과학연구원 신규한 비피도박테리움 비피덤 균주 및 균주 유래 다당체
CN110025639A (zh) * 2019-03-07 2019-07-19 浙江工业大学 酵母葡聚糖组合物在预防便秘中的应用
DK4037666T3 (da) 2020-12-08 2024-06-24 Ruminant Biotech Corp Ltd Forbedring af anordninger og fremgangsmåder til indgivelse af substanser til dyr
WO2023002252A1 (en) * 2021-07-21 2023-01-26 Bioatlantis Limited Composition comprising beta-glucans and alpha-fucans for improving gut health and animal performance and methods of making the same
EP4492986A1 (de) 2022-03-18 2025-01-22 Fumi Holding B.V. Mikrobieller zellextrakt, verfahren zur gewinnung des mikrobiellen zellextrakts und verwendung des mikrobiellen zellextrakts

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739046A (en) 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
DE3605997A1 (de) 1986-02-25 1987-08-27 Teves Gmbh Alfred Blockiergeschuetzte hydraulische bremsanlage
US4891220A (en) 1988-07-14 1990-01-02 Immudyne, Inc. Method and composition for treating hyperlipidemia
US5811542A (en) 1989-09-08 1998-09-22 Alpha-Beta Technology, Inc. Method for producing soluble glucans
US5622939A (en) 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
US6143731A (en) 1989-10-20 2000-11-07 The Collaborative Group, Ltd. Glucan dietary additives
SE469875C (sv) 1991-07-25 1997-04-14 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
US6241983B1 (en) * 1994-10-28 2001-06-05 Metagenics, Inc. Bacteria-and fiber-containing composition for human gastrointestinal health
US5576015A (en) 1995-03-02 1996-11-19 Donzis; Byron A. Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses
AUPN166195A0 (en) 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
US6214337B1 (en) 1995-04-18 2001-04-10 Biotec Asa Animal feeds comprising yeast glucan
US6573250B2 (en) * 1996-06-12 2003-06-03 Takara Shuzo Co., Ltd. Food or beverage additive containing fucoidan and food and beverage containing fucoidan
CA2253573C (en) * 1996-06-12 2005-12-06 Takara Shuzo Co., Ltd. Fucoidan-containing foods or beverages
IT1288713B1 (it) * 1996-12-18 1998-09-23 Crinos Industria Farmaco Fucani a basso peso molecolare aventi attivita' anticoagulante antitrombinica e antitrombotica
US6342242B1 (en) 1998-02-27 2002-01-29 Texas Tech University Seaweed supplement diet for enhancing immune response in mammals and poultry
US6391331B1 (en) 1998-02-27 2002-05-21 Texas Tech University Direct feeding of seaweed supplement to cattle and swine to enhance carcass quality
US6338856B1 (en) 1998-02-27 2002-01-15 Texas Tech University Seaweed supplement diet for enhancing immune response in mammals and poultry
US6383538B1 (en) 1998-02-27 2002-05-07 Texas Tech University Producing meat with enhanced shelf-life
AU6261999A (en) 1998-09-25 2000-04-17 Collaborative Group, Ltd., The Very high molecular weight beta-glucans
DE19962427A1 (de) 1999-12-22 2001-07-12 Nutrinova Gmbh Verkapselte multifunktionelle, biologisch aktive Nahrungsmittelkomponente, Verfahren zu ihrer Herstellung und ihre Anwendung
US6270812B1 (en) 2000-01-31 2001-08-07 Texas Tech University Reducing E. coli content of beef
US6616953B2 (en) 2001-01-02 2003-09-09 Abbott Laboratories Concentrated spent fermentation beer or saccharopolyspora erythraea activated by an enzyme mixture as a nutritional feed supplement
JP2002223727A (ja) * 2001-01-31 2002-08-13 Ribateepu Seiyaku Kk 機能性食品
JP4238726B2 (ja) 2001-06-01 2009-03-18 味の素株式会社 腸疾患用の薬剤
US6939864B1 (en) 2001-07-09 2005-09-06 Purdue Research Foundation Animal feed compositions and methods of using the same
PE20030283A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
KR100436355B1 (ko) * 2001-08-14 2004-06-18 박정호 항산화물질, 옥타코사놀 및 베타글루칸을 함유한 발효음료및 그의 제조방법
JP4169966B2 (ja) * 2001-11-14 2008-10-22 株式会社ヤクルト本社 炎症性腸疾患予防治療剤
US6660722B2 (en) * 2001-11-30 2003-12-09 Laboratoires Goemar S.A. Therapeutical treatments
US6899892B2 (en) 2001-12-19 2005-05-31 Regents Of The University Of Minnesota Methods to reduce body fat
US7018986B2 (en) 2002-09-20 2006-03-28 Immudyne Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption
US20050058671A1 (en) 2003-05-09 2005-03-17 Bedding Peter M.J. Dietary supplement and method for treating digestive system-related disorders
US7223400B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
AU2004281184C1 (en) 2003-10-16 2012-01-12 Techcom Group, Llc Reduced digestible carbohydrate food having reduced blood glucose response
US20050020490A1 (en) 2004-10-18 2005-01-27 Progressive Bioactives Incorporated A Method of Producing an Economical and Ecologically Sound Natural Immunobiotic Extract for Use as a Health Management Instrument and a Replacement for Growth Promotion Antibiotics in Livestock and Companion Animals.
DE202005000192U1 (de) * 2005-01-07 2005-03-24 M C M Klosterfrau Vertriebsgmb Kombinationen aus ß-Glucanen
KR101355266B1 (ko) * 2005-02-15 2014-02-06 배리 알 골딘 생균 및 분리된 β­글루칸을 포함하는 식품 및 이들의 사용방법
US7749545B2 (en) * 2005-03-18 2010-07-06 Sakura Properties, Llc Fucoidan compositions and methods for dietary and nutritional supplements
FR2885812B1 (fr) * 2005-05-18 2007-07-27 Goemar Lab Sa Medicament a base de laminarine ou d'oligolaminarines pour le traitement de la septicemie et du choc septique
WO2007057873A2 (en) 2005-11-21 2007-05-24 Bioatlantis Limited Novel compositions to improve gut health and animal performance and methods of making the same
DK2432478T3 (da) 2009-05-21 2021-12-06 Bioatlantis Ltd Forbedring af gastrointestinal sundhed, immunitet og ydeevne gennem kostintervention

Also Published As

Publication number Publication date
WO2007057873A2 (en) 2007-05-24
EP1965809B1 (de) 2009-09-09
US20090148414A1 (en) 2009-06-11
US12485152B2 (en) 2025-12-02
EP1965809B9 (de) 2010-07-21
US10688140B2 (en) 2020-06-23
EP1965809A2 (de) 2008-09-10
US20200368301A1 (en) 2020-11-26
WO2007057873A3 (en) 2007-11-22
PT1965809E (pt) 2009-12-15
US20180177835A1 (en) 2018-06-28
ES2333259T3 (es) 2010-02-18
DK1965809T3 (da) 2010-01-04
US10780137B2 (en) 2020-09-22
PL1965809T3 (pl) 2010-02-26
DE602006009144D1 (de) 2009-10-22
US20190343905A1 (en) 2019-11-14

Similar Documents

Publication Publication Date Title
MY150602A (en) Subtituted-quinoxaline-type piperidine compounds and the uses thereof
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
MX2010005589A (es) Composicion para el cuidado personal.
PT1984357E (pt) Compostos de 2,4-pirimidinadiamina para tratamento ou prevenção de doenças autoimunes
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
MX337933B (es) Nuevas composiciones para prevenir y/o tratar trastornos de almacenamiento lisosomal.
CY1115825T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν λεβετιρακεταμη και διαδικασια παρασκευης τους
TW200732296A (en) Novel compounds
TW200612892A (en) Novel compounds
SE0301010D0 (sv) Novel compounds
EP2151462A3 (de) Benzylierte aminopropylierte Ethyendiamine und Verwendungen davon
SE0301009D0 (sv) Novel compounds
MX2011012366A (es) Mezclas fungicidas sinergeticas.
MX2007008790A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, metodo de produccion de las mismas, y su uso.
TW200745003A (en) Novel compounds
ATE442153T1 (de) Zusammensetzungen für die verbesserung der darmgesundheit und der tierischen leistung enthaltend beta-glucans and alfa-fucans
WO2007059430A3 (en) Moesin, caveolin 1 and yes associated protein 1 as predictive markers of response to dasatinib in breast cancers
AR065016A1 (es) Composiciones polimericas, metodos para fabricar las mismas y articulos preparados de las mismas
MY148915A (en) An extended-release composition comprising a somatostatin derivative in microparticles
DK2151463T3 (da) Alkyleret aminopropyleret methylen-di-(cyklohexylamin) og anvendelser deraf
MX2010008668A (es) Composiciones fungicidas que comprenden 3'-bromo-2,3,4,6'-tetramet oxy-2'-6-dimetilbenzofenona.
UA88956C2 (ru) Синергическая фунгицидная комбинация действующих веществ
WO2008051862A3 (en) Immunopotentiating compositions comprising beta-1,3/1,6-d-glucan and uses thereof
ATE444990T1 (de) Spritzbare akustikmassen
TW200745039A (en) Isotopically substituted pantoprazole

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1965809

Country of ref document: EP